Does menthol cigarette use moderate the effect of nicotine metabolism on short-term smoking cessation?
- PMID:28493744
- PMCID: PMC5454571
- DOI: 10.1037/pha0000124
Does menthol cigarette use moderate the effect of nicotine metabolism on short-term smoking cessation?
Abstract
The nicotine metabolite ratio (NMR) has been shown to predict response to the transdermal nicotine patch, such that faster nicotine metabolism is associated with a lower abstinence rate. Menthol cigarette use, versus nonmenthol cigarette use, slows nicotine metabolism and therefore may attenuate the effect of NMR on smoking abstinence. In this study, we evaluated whether cigarette type (menthol vs. nonmenthol) modified the association between NMR and short-term abstinence. This was a secondary analysis examining treatment in the first 8 weeks of 21 mg/day nicotine patch therapy in a completed clinical trial (n = 474). Menthol cigarette use was based on self-report. NMR was defined dichotomously (0 = fast, 1 = slow) to distinguish between fast (≥0.47) versus slow NMR. Using logistic regression analysis, we tested whether cigarette type moderated the association between NMR and bioverified 7-day point prevalence abstinence at Week 8. Covariates include nicotine dependence, age, race, and gender. Three hundred two participants reported smoking menthol cigarettes, of which 234 (77%) were classified as slow NMR. Among the 172 nonmenthol smokers, 136 were classified as slow NMR (79%). Contrary to our expectations, the NMR ×Cigarette Type interaction effect on abstinence was not significant (odds ratio [OR] = 0.91, p = .86). Excluding the interaction variable, fast NMR was associated with decreased likelihood of abstinence (OR = 0.55, p = .03), but menthol cigarette use was not (OR = 1.15, p = .56). Further exploration of risk factors among menthol cigarette smokers, especially among racially diverse and light smokers, could clarify the association between menthol cigarette use and poorer smoking outcomes. (PsycINFO Database Record
(c) 2017 APA, all rights reserved).
Conflict of interest statement
Drs. Hitsman and Schnoll receive varenicline and placebo free of charge from Pfizer for use in ongoing National Institutes of Health supported clinical trials. Dr. Hitsman has served on a scientific advisory board for Pfizer. Dr. Schnoll has provided consultation to Pfizer and GlaxoSmithKline. Dr. Tyndale has consulted for Apotex, on unrelated topics. All other authors declare that they have no potential conflicts of interest.
Similar articles
- Nicotine Metabolism in Young Adult Daily Menthol and Nonmenthol Smokers.Fagan P, Pokhrel P, Herzog TA, Pagano IS, Franke AA, Clanton MS, Alexander LA, Trinidad DR, Sakuma KL, Johnson CA, Moolchan ET.Fagan P, et al.Nicotine Tob Res. 2016 Apr;18(4):437-46. doi: 10.1093/ntr/ntv109. Epub 2015 May 19.Nicotine Tob Res. 2016.PMID:25995160Free PMC article.
- Smoking cessation in smokers who smoke menthol and non-menthol cigarettes.Smith SS, Fiore MC, Baker TB.Smith SS, et al.Addiction. 2014 Dec;109(12):2107-17. doi: 10.1111/add.12661. Epub 2014 Jul 21.Addiction. 2014.PMID:24938369Free PMC article.Clinical Trial.
- The Nicotine Metabolite Ratio is Associated With Early Smoking Abstinence Even After Controlling for Factors That Influence the Nicotine Metabolite Ratio.Chenoweth MJ, Schnoll RA, Novalen M, Hawk LW Jr, George TP, Cinciripini PM, Lerman C, Tyndale RF.Chenoweth MJ, et al.Nicotine Tob Res. 2016 Apr;18(4):491-5. doi: 10.1093/ntr/ntv125. Epub 2015 Jun 11.Nicotine Tob Res. 2016.PMID:26069034Free PMC article.Clinical Trial.
- Assessing the evidence on the differential impact of menthol versus non-menthol cigarette use on smoking cessation in the U.S. population: a systematic review and meta-analysis.Kim MM, Curtin GM.Kim MM, et al.Subst Abuse Treat Prev Policy. 2021 Aug 11;16(1):61. doi: 10.1186/s13011-021-00397-4.Subst Abuse Treat Prev Policy. 2021.PMID:34380503Free PMC article.Review.
- Do smokers of menthol cigarettes find it harder to quit smoking?Foulds J, Hooper MW, Pletcher MJ, Okuyemi KS.Foulds J, et al.Nicotine Tob Res. 2010 Dec;12 Suppl 2(Suppl 2):S102-9. doi: 10.1093/ntr/ntq166.Nicotine Tob Res. 2010.PMID:21177366Free PMC article.Review.
Cited by
- A longitudinal study of menthol cigarette use and smoking cessation among adult smokers in the US: Assessing the roles of racial disparities and E-cigarette use.Cook S, Hirschtick JL, Patel A, Brouwer A, Jeon J, Levy DT, Meza R, Fleischer NL.Cook S, et al.Prev Med. 2022 Jan;154:106882. doi: 10.1016/j.ypmed.2021.106882. Epub 2021 Nov 15.Prev Med. 2022.PMID:34793851Free PMC article.
- Menthol Cigarettes and Smoking Cessation among Adult Smokers in the US.Schneller LM, Bansal-Travers M, Mahoney MC, McCann SE, O'Connor RJ.Schneller LM, et al.Am J Health Behav. 2020 Mar 1;44(2):252-256. doi: 10.5993/AJHB.44.2.12.Am J Health Behav. 2020.PMID:32019657Free PMC article.
- Can Treatment Support Mitigate Nicotine Metabolism-Based Disparities in Smoking Abstinence? Secondary Analysis of the Helping HAND 4 Trial.Lee SS, Chang Y, Rigotti NA, Singer DE, Levy DE, Tyndale RF, Davis EM, Freiberg MS, King S, Wells QS, Tindle HA.Lee SS, et al.Nicotine Tob Res. 2023 Aug 19;25(9):1575-1584. doi: 10.1093/ntr/ntad079.Nicotine Tob Res. 2023.PMID:37209421Free PMC article.
- Use of Mentholated Cigarettes and Likelihood of Smoking Cessation in the United States: A Meta-Analysis.Smith PH, Assefa B, Kainth S, Salas-Ramirez KY, McKee SA, Giovino GA.Smith PH, et al.Nicotine Tob Res. 2020 Mar 16;22(3):307-316. doi: 10.1093/ntr/ntz067.Nicotine Tob Res. 2020.PMID:31204787Free PMC article.Review.
References
- Alexander LA, Trinidad DR, Sakuma KL, Pokhrel P, Herzog TA, Clanton MS, … Fagan P. Why We Must Continue to Investigate Menthol’s Role in the African American Smoking Paradox. Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco. 2016;18(Suppl 1):S91–101. doi: 10.1093/ntr/ntv209. - DOI - PMC - PubMed
Publication types
MeSH terms
Substances
Related information
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical